POST-COVID COGNITIVE IMPAIRMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS-Reference-Cited by-同舟云学术

POST-COVID COGNITIVE IMPAIRMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Published:2022 Issue:8 Volume:75 Page:1895-1899
ISSN:0043-5147
Container-title:Wiadomości Lekarskie
language:en
Short-container-title:Wiad Lek

Author:

Kohut Anna O.¹,Chaban Oleg S.¹,Burdeinyi Andrii O.¹,Dolynskyi Roman G.¹,Bursa Andrii I.¹,Bobryk Maryna I.¹,Gershanov Alexander²

Affiliation:

1. BOGOMOLETS NATIONAL MEDICAL UNIVERSITY, KYIV, UKRAINE

2. ISRAEL TRAUMA COALITION, JERUSALEM, ISRAEL

Abstract

The aim: The revealing of the consequences of the long-term postcovid effects on the particular cognitive domains in patients with diabetes mellitus type 2 (DM 2) by comparing the characteristics of patients with DM 2 without postcovid disorders and the characteristics of cognitive impairment in patients with long-therm postcovid without DM 2 by forming the research hypothesis to improve the adherence to treatment of patients. Materials and methods: Literature search was performed using PubMed search criteria “covid AND cognitive AND domain” 217 articles, as a result, and separately “diabetes mellitus 2 type AND cognitive impairment AND domain” with the result of 164 articles. There were 26 remaining studies included in this review. The hypothesis about the relationships between the particular cause factors and the defeating of specific cognitive domains in patients with DM 2 in the long-term postcovid period has been formed. Conclusions: This is important in the terms of the influence of cognitive impairment on the concordance to treatment process and quality of life level in patients with DM 2 in general. So, involving specialists of different profiles in a multidisciplinary approach is the solution to this issue.

Publisher

ALUNA

Subject

General Medicine

Reference38 articles.

1. 1. Maltezou H.C., Pavli A., Tsakris A. Postcovid Syndrome: An Insight on Its Pathogenesis. Vaccines (Basel). 2021;9(5):497. doi:10.3390/ vaccines9050497.

2. 2. Taquet M., Dercon Q., Luciano S. et al. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9):e1003773. doi:10.1371/journal.pmed.1003773.

3. 3. Kincaid K.J., Kung J.C., Senetar A.J. et al. Postcovid seizure: A new feature of «long-COVID». EneurologicalSci. 2021;23:100340. doi:10.1016/j. ensci.2021.100340.

4. 4. Lyra E Silva N.M., Barros-Aragão F.G.Q., De Felice F.G. et al. Inflammation at the crossroads of COVID-19, cognitive deficits and depression. Neuropharmacology. 2022;209:109023. doi:10.1016/j. neuropharm.2022.109023.

5. 5. Bandeira I.P., Schlindwein M.A.M.., Breis L.C. et al. Neurological Complications of the COVID-19 Pandemic: What Have We Got So Far?. Adv Exp Med Biol. 2021;1321:21-31. doi:10.1007/978-3-030- 59261-5_2.